The National Institute of Health, Clinical Center intends to award a fixed price purchase order to Life Technologies Corporation, Carlsbad CA, 92008-7313, on a sole source basis to procure reagents and testing kits that has been quality controlled for use on the existing government owned 3730xl instrumentation for the Human Leukocyte Antigen (HLA) laboratory of the Clinical Center.

Life Technologies is the sole manufacturer for the HLA SeCore ® sequencing product assay and associated proprietary uType ® HLA Analysis Software. The comprehensive system of instruments and consumables is necessary to produce a complete typing result. The acquisition of reagents and kits are needed to perform high resolution testing for transplant patients and donors who must both be matched for peripheral blood stem cell and cord blood transplants. Life Technologies is the only known vendor who can supply the necessary products listed in the Attachment, Schedule of Supplies.

The Government shall consider all responses received prior to the close date of this announcement. Written responses to this notice shall contain sufficient documentation to establish bonafide capability to fulfill the requirements established above. All responses must be received no later than March 25, 2013, 05:00PM, Eastern Standard Time and directed to Malinda Dehner, Contract Specialist at [email protected].